# A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)

> **NCT01911598** · PHASE1 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** 5-FU
- **DRUG:** Carboplatin
- **DRUG:** Cisplatin
- **DRUG:** MEHD7945A
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT01911598
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-19
- **Primary completion:** 2017-06-22
- **Final completion:** 2017-06-22
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01911598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01911598, "A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01911598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*